Discover
TNXP
Tonix Pharmaceuticals Holding Corp.
7.30
2 x 5.34
2 x 9.12
bid
ask
+
0.02
0.27%
2 @ 07:16 PM
7.35 +0.05 (0.70%)
| Ytd | -53.27% | |
| 1y | -67.61% |
7.10
day range
7.54
7.28
52 week range
22.54
| Open | 7.27 | Prev Close | 7.28 | Low | 7.10 | High | 7.54 | Mkt Cap | 125.20M |
| Vol | 963.56K | Avg Vol | 550.08K | EPS | -13.06 | P/E | N/A | Forward P/E | -0.01 |
| Beta | 2.08 | Short Ratio | 0.35 | Inst. Own | 0.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 11.42 | 200-d Avg | 13.24 | 1yr Est | 5.83 |
| Income Statement | |||
| Total Revenue | 13.54M | ||
| Revenues (USD) | 13.54M | ||
| Cost of Revenue | 703.00K | ||
| Gross Profit | 12.84M | ||
| Operating Expenses | 55.38M | ||
| Research and Development Expense | 19.42M | ||
| Selling, General and Administrative Expense | 35.96M | ||
| Operating Income | -42.53M | ||
| Net Income | -40.55M | ||
| Net Income Common Stock | -40.55M | ||
| Net Income Common Stock (USD) | -40.55M | ||
| Consolidated Income | -40.55M | ||
| Earnings per Basic Share | -2.44 | ||
| Earnings per Basic Share (USD) | -2.44 | ||
| Earnings per Diluted Share | -2.44 | ||
| Earning Before Interest & Taxes (EBIT) | -40.55M | ||
| Earning Before Interest & Taxes (USD) | -40.55M | ||
| Weighted Average Shares | 16.64M | ||
| Weighted Average Shares Diluted | 16.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 176.23M | ||
| Cash and Equivalents (USD) | 176.23M | ||
| Trade and Non-Trade Receivables | 11.81M | ||
| Current Assets | 203.43M | ||
| Property, Plant & Equipment Net | 46.11M | ||
| Total Assets | 254.09M | ||
| Debt Current | 250.00K | ||
| Total Debt | 1.27M | ||
| Current Liabilities | 30.79M | ||
| Debt Non-Current | 1.02M | ||
| Total Liabilities | 31.81M | ||
| Accumulated Retained Earnings (Deficit) | -935.46M | ||
| Accumulated Other Comprehensive Income | -348.00K | ||
| Shareholders Equity | 222.28M | ||
| Shareholders Equity (USD) | 222.28M | ||
| Assets Non-Current | 50.66M | ||
| Total Debt (USD) | 1.27M | ||
| Inventory | 4.68M | ||
| Liabilities Non-Current | 1.02M | ||
| Trade and Non-Trade Payables | 9.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 619.00K | ||
| Net Cash Flow from Financing | 33.51M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.39M | ||
| Capital Expenditure | -587.00K | ||
| Issuance (Purchase) of Equity Shares | 33.51M | ||
| Net Cash Flow from Investing | -587.00K | ||
| Net Cash Flow from Operations | -42.24M | ||
| Effect of Exchange Rate Changes on Cash | -64.00K | ||
| Share Based Compensation | 2.26M | ||